Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 5 | 6 |
| List of Tables | 7 | 2 |
| List of Figures | 9 | 2 |
| Drug Discovery and Development Market in Asia - Introduction | 11 | 1 |
| Drug Discovery and Development Market in Asia - Overview | 12 | 5 |
| Introduction | 12 | 1 |
| New Molecule Entity Applications Filed and Approved | 12 | 2 |
| Total Industry Spend on R&D and Cost to Develop New Drug | 14 | 1 |
| Industry Trends | 15 | 1 |
| Spending on R&D | 15 | 1 |
| R&D Expenditure, Percent Invested on the Development of Biologics | 16 | 1 |
| Drug Discovery and Development Market in Asia - Market Segmentation | 17 | 21 |
| Industry-Sponsored Phase II/III Trials | 19 | 3 |
| Clinical Trials by Therapy Area | 22 | 2 |
| Drug Discovery and Development Market Size | 24 | 2 |
| China | 26 | 2 |
| India | 28 | 2 |
| Russia | 30 | 2 |
| Japan | 32 | 2 |
| South Korea | 34 | 2 |
| Singapore | 36 | 1 |
| Taiwan | 37 | 1 |
| Drug Discovery and Development Market in Asia - Strategic Locations | 38 | 14 |
| Population | 38 | 2 |
| Patients Recruited | 40 | 1 |
| Contract Research Organizations (CRO) | 41 | 2 |
| Total Number of Sites for Clinical Trials | 43 | 3 |
| Gross Domestic Product (Purchasing Power Parity) | 46 | 1 |
| Total Healthcare Expenditure as a Percentage of GDP | 47 | 1 |
| Cost Comparison | 48 | 1 |
| Tax Credits | 48 | 1 |
| China | 48 | 1 |
| Japan | 48 | 1 |
| South Korea | 48 | 1 |
| Taiwan | 49 | 1 |
| Singapore | 49 | 1 |
| Russia | 49 | 1 |
| India | 49 | 1 |
| Comparison between Countries | 50 | 2 |
| Drug Discovery and Development Market in Asia - Strategic Shift in R&D | 52 | 18 |
| Introduction | 52 | 1 |
| Switch from Linear Blockbuster Model to Innovation Model | 53 | 2 |
| Innovation Model | 55 | 1 |
| Global Multinational Corporations | 56 | 1 |
| The Biotechs | 56 | 1 |
| Niche Services Companies | 57 | 1 |
| Asian Biopharmaceuticals | 58 | 1 |
| Strategies for Designing Drug Discovery and Development Model for Global Market | 58 | 2 |
| R&D Rise in Asia | 60 | 3 |
| R&D by Geographic Area, PhRMA Member Companies, 2010 | 63 | 2 |
| New Strategic Outsourcing Models to Meet Changing Clinical Development Needs | 65 | 1 |
| Tactical Outsourcing | 65 | 1 |
| referred Provider Relationship | 65 | 1 |
| Functional Service Provider Model | 66 | 1 |
| Business Process Outsourcing | 66 | 1 |
| Full-Development Outsourcing | 66 | 1 |
| Technology - Central Lab Service Model | 67 | 3 |
| Drug Discovery and Development Market in Asia - Regulatory Landscape | 70 | 21 |
| Introduction | 70 | 1 |
| Taiwan | 71 | 2 |
| South Korea | 73 | 1 |
| IND Application Process | 73 | 1 |
| NDA Approval Process | 74 | 1 |
| Japan | 74 | 1 |
| IND Application Process | 74 | 2 |
| NDA Approval Process | 76 | 1 |
| Russia | 76 | 1 |
| Timelines for Obtaining Approval for Conducting Clinical Trials in Russia | 77 | 1 |
| India | 77 | 1 |
| Clinical Trials Registry India | 77 | 2 |
| Clinical Trial Regulation in India | 79 | 2 |
| Timeframe for Approval | 81 | 1 |
| China | 82 | 1 |
| The Ministry of Health | 82 | 1 |
| State Food and Drug Administration | 82 | 1 |
| Clinical Trials Registry China | 83 | 1 |
| Clinical Trial Regulation in China | 84 | 1 |
| Approval Process for Clinical Trials in China | 84 | 1 |
| Number of Days Required for Obtaining Approval for Clinical Trials (Individual Procedures) | 85 | 1 |
| Approval Process for Clinical Trials in China for Imported Drugs | 86 | 1 |
| Number of Days Required for Obtaining Approval for Clinical Trials for Imported Drugs (Individual Procedures) | 87 | 1 |
| Structure and Procedure for Monitoring Adverse Drug Reactions in China | 88 | 1 |
| Singapore | 89 | 2 |
| Drug Discovery and Development Market in Asia - Leading Five CROs | 91 | 7 |
| Quintiles | 91 | 2 |
| Pharmaceutical Product Development | 93 | 2 |
| Covance | 95 | 1 |
| PAREXEL International Corporation | 96 | 1 |
| Charles River Laboratories International | 97 | 1 |
| Drug Discovery and Development Market in Asia - Deals Analysis | 98 | 3 |
| By Year | 98 | 1 |
| By Phase | 99 | 1 |
| By Type | 100 | 1 |
| Drug Discovery and Development Market in Asia - Appendix | 101 | 6 |
| Market Definitions | 101 | 1 |
| Abbreviations | 101 | 1 |
| Bibliography | 102 | 2 |
| Research Methodology | 104 | 2 |
| Coverage | 104 | 1 |
| Secondary Research | 105 | 1 |
| Primary Research | 105 | 1 |
| Expert Panel Validation | 105 | 1 |
| Contact Us | 106 | 1 |
| Disclaimer | 106 | 1 |